Literature DB >> 14978103

A peptide that antagonizes TCR-mediated reactions with both syngeneic and allogeneic agonists: functional and structural aspects.

Markus G Rudolph1, Lucy Q Shen, Stephen A Lamontagne, John G Luz, Joseph R Delaney, Qing Ge, Bryan K Cho, Deborah Palliser, Carol A McKinley, Jianzhu Chen, Ian A Wilson, Herman N Eisen.   

Abstract

We identify and consider some characteristics of a peptide antagonist for the Ag-specific receptor on 2C cells (the 2C TCR). The peptide, GNYSFYAL (called GNY), binds to H-2K(b), and a very high-resolution crystal structure of the GNY-K(b) complex at 1.35 A is described. Although the GNY peptide does not bind to L(d), the potency of GNY-K(b) as an antagonist is evident from its ability to specifically inhibit 2C TCR-mediated reactions to an allogenic agonist complex (QLSPFPFDL-L(d)), as well as to a syngeneic agonist complex (SIYRYYGL-K(b)). The crystal structure and the activities of alanine-substituted peptide variants point to the properties of the peptide P4 side chain and the conformation of the Tyr-P6 side chain as the structural determinants of GNYSFYAL antagonist activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14978103     DOI: 10.4049/jimmunol.172.5.2994

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors.

Authors:  Erin J Adams; Z Sean Juo; Rayna Takaki Venook; Martin J Boulanger; Hisashi Arase; Lewis L Lanier; K Christopher Garcia
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-30       Impact factor: 11.205

2.  Antagonism of HIV-specific CD4+ T cells by C-terminal truncation of a minimum epitope.

Authors:  Philip J Norris; Jennifer D Stone; Nadezhda Anikeeva; John W Heitman; Ingrid C Wilson; Dale F Hirschkorn; Margaret J Clark; Howell F Moffett; Thomas O Cameron; Yuri Sykulev; Lawrence J Stern; Bruce D Walker
Journal:  Mol Immunol       Date:  2005-10-07       Impact factor: 4.407

3.  Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.

Authors:  Jennifer D Stone; David H Aggen; Adam S Chervin; Samanthi Narayanan; Thomas M Schmitt; Philip D Greenberg; David M Kranz
Journal:  J Immunol       Date:  2011-03-30       Impact factor: 5.422

Review 4.  Structural Prediction of Peptide-MHC Binding Modes.

Authors:  Marta A S Perez; Michel A Cuendet; Ute F Röhrig; Olivier Michielin; Vincent Zoete
Journal:  Methods Mol Biol       Date:  2022

5.  Comparison of the aggregation of homologous β2-microglobulin variants reveals protein solubility as a key determinant of amyloid formation.

Authors:  Clare L Pashley; Eric W Hewitt; Sheena E Radford
Journal:  J Mol Biol       Date:  2016-01-15       Impact factor: 5.469

6.  Visualization of transient protein-protein interactions that promote or inhibit amyloid assembly.

Authors:  Theodoros K Karamanos; Arnout P Kalverda; Gary S Thompson; Sheena E Radford
Journal:  Mol Cell       Date:  2014-06-26       Impact factor: 17.970

7.  A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function.

Authors:  Evan S Jacobs; Desmond Persad; Longsi Ran; Ali Danesh; John W Heitman; Xutao Deng; Mark J Cameron; David J Kelvin; Philip J Norris
Journal:  Retrovirology       Date:  2014-07-05       Impact factor: 4.602

8.  A Population Shift between Sparsely Populated Folding Intermediates Determines Amyloidogenicity.

Authors:  Theodoros K Karamanos; Clare L Pashley; Arnout P Kalverda; Gary S Thompson; Maxim Mayzel; Vladislav Y Orekhov; Sheena E Radford
Journal:  J Am Chem Soc       Date:  2016-05-06       Impact factor: 15.419

9.  DockTope: a Web-based tool for automated pMHC-I modelling.

Authors:  Maurício Menegatti Rigo; Dinler Amaral Antunes; Martiela Vaz de Freitas; Marcus Fabiano de Almeida Mendes; Lindolfo Meira; Marialva Sinigaglia; Gustavo Fioravanti Vieira
Journal:  Sci Rep       Date:  2015-12-17       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.